Finance

Lists
NSB:ASX
Neuroscientific Biopharmaceuticals Ltd
0,062 A$
+1,64%
(+0,00100) 1D
1 қаз., 16:10:19 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NSB...
Open
0,06 A$
High
0,06 A$
Low
0,06 A$
Mkt. cap
24,16 млн
Avg. vol.
154,62 м.
Volume
2,64 мың
52-wk high
0,18 A$
52-wk low
0,06 A$
EPS
-0,01 A$
Shares outstanding
389,72 млн
Open
0,06 A$
High
0,06 A$
Low
0,06 A$
Mkt. cap
24,16 млн
Avg. vol.
154,62 м.
Volume
2,64 мың
52-wk high
0,18 A$
52-wk low
0,06 A$
EPS
-0,01 A$
Shares outstanding
389,72 млн
News stories
From web sources and news partners
About Neuroscientific Biopharmaceuticals Ltd
CEO-
Employees-
Founded2002
Headquarters-
Sector-
Last report
2026 ж. 28 шіл.
Fiscal period
Q4 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
42,38 мың / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
158,95 м.
158,95 м.
42,38 мың
42,38 мың
Cost of goods sold
23,53 мың
23,53 мың
48,66 мың
48,66 мың
Cost of revenue
23,53 мың
23,53 мың
48,66 мың
48,66 мың
Research and development expenses
225,61 м.
225,61 м.
316,20 м.
316,20 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
409,06 м.
409,06 м.
628,30 м.
628,30 м.
Operating expense
1,04 млн
1,04 млн
1,44 млн
1,44 млн
Total operating expenses
1,07 млн
1,07 млн
1,49 млн
1,49 млн
Operating income
-908,64 м.
-908,64 м.
-1,44 млн
-1,44 млн
Other non operating income
-
-
-
-
EBT including unusual items
-849,71 м.
-849,71 м.
-1,50 млн
-1,50 млн
EBT excluding unusual items
-849,71 м.
-849,71 м.
-1,39 млн
-1,39 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-849,71 м.
-849,71 м.
-1,50 млн
-1,50 млн
Net profit margin
-534,56%
-534,56%
-3 532,28%
-3 532,28%
Earnings per share
-
-
-
-
Interest and investment income
59,20 мың
59,20 мың
54,17 мың
54,17 мың
Interest expense
-263,00
-263,00
-1,57 мың
-1,57 мың
Net interest expenses
58,94 мың
58,94 мың
52,60 мың
52,60 мың
Depreciation and amortization charges
383,00
383,00
6,24 мың
6,24 мың
EBITDA
-597,26 м.
-597,26 м.
-1,06 млн
-1,06 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары